Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

QTRX

Quanterix Corp

Feb 06 • 04:00PM ET

6.09

+0.21 3.57 %

Healthcare • Medical Devices • USA • NASD

Peers: ILMN NTRA TWST GH EXAS TMO ABT DHR BIO QGEN

| Held by: VTI IWM VXF IWN IBB VTWO SCHA FESM DFAS VHT

Index	RUT	P/E	-	EPS (ttm)	-2.33	Insider Own	18.68%	Shs Outstand	46.68M	Perf Week	-3.94%
Market Cap	284.47M	Forward P/E	-	EPS next Y	-1.27	Insider Trans	0.05%	Shs Float	37.99M	Perf Month	-8.14%
Enterprise Value	189.78M	PEG	-	EPS next Q	-0.45	Inst Own	77.40%	Short Float	8.99%	Perf Quarter	17.79%
Income	-95.66M	P/S	2.18	EPS this Y	-126.82%	Inst Trans	0.32%	Short Ratio	4.55	Perf Half Y	10.53%
Sales	130.20M	P/B	0.90	EPS next Y	44.20%	ROA	-22.37%	Short Interest	3.42M	Perf YTD	-4.25%
Book/sh	6.74	P/C	2.11	EPS next 5Y	-1.72%	ROE	-29.28%	52W High	8.81 -30.87%	Perf Year	-29.68%
Cash/sh	2.89	P/FCF	-	EPS past 3/5Y	14.43% 9.19%	ROIC	-27.63%	52W Low	4.05 50.37%	Perf 3Y	-57.56%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	7.52% 19.36%	Gross Margin	54.28%	Volatility	7.77% 8.73%	Perf 5Y	-91.23%
Dividend TTM	-	EV/Sales	1.46	EPS Y/Y TTM	-149.18%	Oper. Margin	-74.61%	ATR (14)	0.50	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.31	Sales Y/Y TTM	-2.69%	Profit Margin	-73.47%	RSI (14)	41.35	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.02	EPS Q/Q	-235.04%	SMA20	-11.47%	Beta	1.07	Target Price	7.50
Payout	-	Debt/Eq	0.13	Sales Q/Q	12.34%	SMA50	-12.33%	Rel Volume	0.76	Prev Close	5.88
Employees	471	LT Debt/Eq	0.10	Earnings	Nov 10 AMC	SMA200	4.01%	Avg Volume	749.96K	Price	6.09
IPO	Dec 07, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	-59.56% 6.76%	Trades		Volume	567,195	Change	3.57%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-11-25	Downgrade	Canaccord Genuity	Buy → Hold	$5
Feb-01-24	Initiated	Scotiabank	Sector Outperform	$30
Sep-25-23	Upgrade	Canaccord Genuity	Hold → Buy	$25 → $32
Aug-08-23	Upgrade	SVB Securities	Market Perform → Outperform	$30
May-23-23	Upgrade	Goldman	Neutral → Buy	$13 → $27
Aug-15-22	Downgrade	Canaccord Genuity	Buy → Hold	$40 → $12
Aug-09-22	Downgrade	SVB Leerink	Outperform → Mkt Perform	$35 → $15
Aug-09-22	Downgrade	Cowen	Outperform → Market Perform	$38 → $18
Mar-02-22	Upgrade	Goldman	Sell → Neutral	$40
Oct-15-21	Resumed	Cowen	Outperform
Jun-04-21	Initiated	Goldman	Sell	$53

Show Previous Ratings

Feb-04-26 12:57PM	Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer's Blood Test (Zacks)
Feb-03-26 08:33AM	Quanterix Announces FDA 510(k) Submission for a Multi-Analyte Algorithmic Blood Test for Alzheimers Disease Detection (Business Wire)
Jan-21-26 08:33AM	Quanterix Announces Landmark JAMA Study Highlighting Prognostic Value of Multi-Analyte Approach to Blood-Based Alzheimer's Risk Profiling (Business Wire)
Jan-16-26 04:01PM	Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -6.92% -5.14%
Jan-08-26 04:30PM	Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026 (Business Wire) +23.81%
07:30AM	Loading…
Dec-22-25 07:30AM	Quanterix Announces Landmark Nature Study Redefining Alzheimer's Disease Neuropathology Prevalence (Business Wire)
Nov-20-25 04:15PM	Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth (Business Wire) +12.69%
Nov-17-25 05:30PM	Quanterix Announces Landmark Study Demonstrating Dual GFAP/NfL Blood Test Approach for Personalized Multiple Sclerosis Monitoring (Business Wire)
Nov-11-25 12:02AM	Quanterix Corp (QTRX) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
Nov-10-25 05:10PM	Quanterix Corporation (QTRX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Quanterix Releases Financial Results for the Third Quarter of 2025 (Business Wire)
Nov-07-25 07:35AM	Sanuwave Health Inc. (SNWV) Beats Q3 Earnings and Revenue Estimates (Zacks)
07:22AM	Earnings To Watch: Quanterix Corp (QTRX) Reports Q3 2025 Result (GuruFocus.com)
Nov-03-25 07:00AM	Quanterix To Report Third Quarter 2025 Financial Results on November 10, 2025 (Business Wire)
Oct-02-25 12:00PM	All You Need to Know About Quanterix (QTRX) Rating Upgrade to Buy (Zacks)
04:30PM	Loading…
Aug-21-25 04:30PM	Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit (Business Wire)
Aug-12-25 09:35AM	Down 24.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Quanterix (QTRX) (Zacks)
Aug-11-25 07:00AM	Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference (Business Wire)
Aug-07-25 06:35PM	Quanterix Corporation (QTRX) Reports Q2 Loss, Misses Revenue Estimates (Zacks) -13.79%
04:06PM	Quanterix Releases Financial Results for the Second Quarter of 2025 (Business Wire)
Aug-04-25 04:02PM	Quanterix To Report Second Quarter 2025 Financial Results on August 7, 2025 (Business Wire)
09:30AM	Quanterix Announces Cooperation Agreement with Kent Lake Capital (Business Wire)
Jul-28-25 07:00AM	Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC (Business Wire) +10.94%
Jul-24-25 08:45AM	Exagen (XGN) Soars 5.5%: Is Further Upside Left in the Stock? (Zacks)
Jul-11-25 05:00PM	Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jul-08-25 09:07AM	Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum (Business Wire)
Jun-23-25 07:30AM	Quanterix Expands Reach with IVD and Large Reference Labs (Business Wire)
Jun-11-25 08:00AM	Kent Lake Condemns Quanterix's Failure to Schedule Its 2025 Annual Meeting as a Tactic to Silence Shareholders (PR Newswire)
Jun-06-25 09:41AM	Quanterix to Present at Goldman Sachs Global Healthcare Conference (Business Wire)
May-23-25 02:21PM	Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal (PR Newswire)
09:10AM	Loading…
09:10AM	New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs (PR Newswire)
May-13-25 03:09AM	Quanterix Corp (QTRX) Q1 2025 Earnings Call Highlights: Record Consumables Revenue Amidst ... (GuruFocus.com) -19.02%
May-12-25 05:10PM	Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +8.52%
04:01PM	Quanterix Releases Financial Results for the First Quarter of 2025 (Business Wire)
May-09-25 09:42AM	Earnings To Watch: Quanterix Corp (QTRX) Reports Q1 2025 Result (GuruFocus.com)
May-07-25 07:40PM	Phibro Animal Health (PAHC) Q3 Earnings Beat Estimates (Zacks)
May-05-25 07:00AM	Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025 (Business Wire)
Apr-30-25 08:00AM	Kent Lake Issues Statement on Quanterix's Blatant Disregard for Will of Shareholders (Business Wire)
Apr-29-25 07:00AM	Quanterix and Akoya Biosciences Announce Amended Merger Agreement (Business Wire)
Apr-17-25 08:30AM	Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders (Business Wire)
Apr-14-25 08:00AM	Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences (Business Wire) +7.69%
Apr-07-25 08:15AM	Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya (Business Wire) -12.96%
Apr-02-25 09:41AM	Quanterix: Still Many, Many Questions (Seeking Alpha)
Apr-01-25 01:00AM	Quanterix Showcases Innovation Powered by Simoa at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit (Business Wire)
Mar-24-25 11:03AM	Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences (Business Wire)
Mar-19-25 04:10PM	SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN (PR Newswire)
Mar-18-25 09:18AM	Q4 2024 Quanterix Corp Earnings Call (Thomson Reuters StreetEvents)
03:01AM	Quanterix Corp (QTRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges (GuruFocus.com)
Mar-17-25 04:01PM	Quanterix Releases Financial Results for the Fourth Quarter of 2024 (Business Wire)
04:00PM	Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Todays Earnings Call (Business Wire)
04:00PM	Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results (GlobeNewswire)
Mar-13-25 01:00PM	Quanterix To Report Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025 (Business Wire)
Mar-11-25 08:00AM	Kent Lake Issues Investor Presentation Detailing Opposition to Quanterixs Proposed Merger with Akoya Biosciences (Business Wire)
Mar-03-25 08:00AM	Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board (Business Wire) -6.59%
06:00AM	Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition (Business Wire)
Feb-18-25 03:40PM	Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Companys Proposed Merger with Akoya Biosciences (Business Wire)
Jan-14-25 07:00AM	Quanterix Provides Update on Financial Performance (Business Wire) -5.93%
Jan-10-25 07:00AM	Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers (Business Wire) -19.69%
Jan-06-25 09:30AM	David R. Walt Receives National Medal of Technology and Innovation (Business Wire)
Jan-02-25 04:26PM	Quanterix to Present at the 43rd Annual J.P. Morgan Healthcare Conference (Business Wire) +12.27%
Dec-27-24 04:33AM	Down More Than 60%: Analysts Expect These 2 Beaten-Down Stocks to Rebound in 2025 (TipRanks)
Dec-17-24 06:59AM	Quanterix Expands Capabilities with Strategic Acquisition of EMISSION (Business Wire)
Nov-22-24 05:00PM	Quanterix Announces Receipt of Expected Notice from Nasdaq (Business Wire) +5.70%
07:54AM	Wolf Haldenstein Adler Freeman and Herz LLP announces that it is investigating Quanterix Corporation for potential violations of securities laws (GlobeNewswire)
Nov-21-24 07:00AM	Wolf Haldenstein Adler Freeman and Herz LLP announces that it is investigating Quanterix Corporation for potential violations of securities laws (PR Newswire) +6.35%
Nov-13-24 02:18AM	Quanterix Corp (QTRX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Instrument ... (GuruFocus.com) -18.26%
Nov-12-24 04:01PM	Quanterix Releases Preliminary Financial Results for the Third Quarter of 2024 (Business Wire)
Nov-11-24 07:14AM	Quanterix Corp (QTRX) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Nov-05-24 04:00PM	Quanterix To Report Third Quarter 2024 Financial Results on November 12, 2024 (Business Wire) +5.99%
Oct-28-24 04:30PM	New Multi-Marker Blood Test from Lucent Diagnostics Increases the Number of Patients Receiving Early Alzheimer's Disease Diagnostic Information (Business Wire) +5.02%
Oct-09-24 05:55PM	Quanterix Corp (QTRX) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amid Regional ... (GuruFocus.com)
Oct-02-24 04:00PM	Quanterix Welcomes Ivana Magovevi-Liebisch, Ph.D., J.D. to Board of Directors (Business Wire)
Sep-30-24 04:00PM	Quanterix Announces Commercialization of p-Tau 217 Test Kit (Business Wire)
Aug-29-24 04:00PM	Quanterix to Participate at the Morgan Stanley 22nd Annual Global Healthcare Conference (Business Wire)
Aug-19-24 04:32PM	Jeffrey Elliott Appointed to Quanterixs Board of Directors (Business Wire) +7.66%
Aug-15-24 07:18PM	Insider Buying: President & CEO Masoud Toloue Acquires Shares of Quanterix Corp (QTRX) (GuruFocus.com) +9.25%
Aug-08-24 05:10PM	Quanterix Corporation (QTRX) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -14.82%
04:00PM	Quanterix Releases Financial Results for the Second Quarter of 2024 (Business Wire)
Aug-06-24 04:00PM	Quanterix Presenting at Canaccord Genuity 44th Annual Growth Conference (Business Wire) -5.26%
Jul-31-24 04:00PM	Quanterix To Report Second Quarter 2024 Financial Results (Business Wire)
Jul-29-24 10:00AM	Analysts Estimate Quanterix Corporation (QTRX) to Report a Decline in Earnings: What to Look Out for (Zacks) -6.62%
08:00AM	Quanterix Presents Data Demonstrating Successful Multi-Marker Approach for Alzheimers Disease Detection that is More Effective than Standalone Plasma p-Tau 217 (Business Wire)
Jun-17-24 04:00PM	Quanterix to Participate at the Scotiabank Healthcare 1x1 Day (Business Wire) +5.48%
Jun-05-24 04:00PM	Quanterix to Present at 45th Annual Goldman Sachs Global Healthcare Conference (Business Wire)
May-22-24 04:00PM	Quanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024 (Business Wire)
May-15-24 09:55AM	Wall Street Analysts Believe Quanterix (QTRX) Could Rally 67.66%: Here's is How to Trade (Zacks) +6.30%
May-09-24 04:45PM	Quanterix Corporation (NASDAQ:QTRX) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:10AM	Quanterix Corp (QTRX) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth and ... (GuruFocus.com)
May-07-24 09:00PM	QTRX Stock Earnings: Quanterix Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:10PM	Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:00PM	Quanterix Releases Financial Results for the First Quarter of 2024 (Business Wire)
Apr-29-24 04:00PM	Quanterix To Report First Quarter 2024 Financial Results (Business Wire)
11:13AM	Canaccord Genuity Adjusts Price Target on Quanterix to $25 From $32, Maintains Buy Rating (MT Newswires)
Mar-21-24 05:30PM	Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer's Disease Testing Infrastructure (Business Wire)
Mar-06-24 09:50AM	Quanterix (QTRX) AD Offering Gets FDA's Breakthrough Device Tag (Zacks)
Mar-04-24 09:00AM	Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimers Disease (Business Wire)
Mar-03-24 08:16AM	Quanterix Corporation (NASDAQ:QTRX) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 09:26AM	Q4 2023 Quanterix Corp Earnings Call (Thomson Reuters StreetEvents) +12.69%
Feb-29-24 05:10PM	Quanterix Corporation (QTRX) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:00PM	Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023 (Business Wire)

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sriram Vandana	Chief Financial Officer	Sep 12 '25	Buy	4.79	4,150	19,878	87,200	Sep 17 10:24 AM
WALT DAVID R	Director	Jun 13 '25	Buy	6.14	123,990	760,803	1,866,933	Jun 13 04:39 PM
WALT DAVID R	Director	Jun 12 '25	Buy	6.23	36,010	224,166	1,742,943	Jun 13 04:39 PM
Toloue Masoud	President & CEO	Jun 09 '25	Buy	5.42	45,900	248,723	518,922	Jun 10 04:08 PM
WALT DAVID R	Director	Jun 06 '25	Buy	5.43	131,869	716,576	1,628,802	Jun 09 05:44 PM
WALT DAVID R	Director	Jun 09 '25	Buy	5.34	78,131	417,220	1,706,933	Jun 09 05:44 PM
DONNELLY WILLIAM P	Director	Jun 06 '25	Buy	5.44	93,113	506,348	139,094	Jun 09 05:10 PM

Open in Screener

MASS

908 Devices Inc

Feb 06 • 04:00PM ET

6.55

+0.35 5.65 %

Healthcare • Medical Devices • USA • NASD

Peers: DHR A BRKR BIO WAT TECH MTD IART CAMT

| Held by: ARKG IWM VTI VXF IWO SCHA FITE VTWO IWC AVSC

Index	RUT	P/E	-	EPS (ttm)	-1.71	Insider Own	25.74%	Shs Outstand	36.12M	Perf Week	3.80%
Market Cap	237.06M	Forward P/E	-	EPS next Y	-0.32	Insider Trans	-0.72%	Shs Float	26.73M	Perf Month	20.18%
Enterprise Value	129.36M	PEG	-	EPS next Q	-0.07	Inst Own	73.87%	Short Float	12.44%	Perf Quarter	-19.14%
Income	-60.66M	P/S	4.11	EPS this Y	70.77%	Inst Trans	2.69%	Short Ratio	7.36	Perf Half Y	2.02%
Sales	57.64M	P/B	1.74	EPS next Y	48.25%	ROA	-30.94%	Short Interest	3.32M	Perf YTD	24.76%
Book/sh	3.77	P/C	2.12	EPS next 5Y	48.47%	ROE	-42.72%	52W High	9.34 -29.87%	Perf Year	147.17%
Cash/sh	3.10	P/FCF	-	EPS past 3/5Y	-38.77% -32.72%	ROIC	-43.27%	52W Low	1.92 241.15%	Perf 3Y	-30.54%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	12.21% 27.11%	Gross Margin	45.54%	Volatility	5.68% 5.72%	Perf 5Y	-88.06%
Dividend TTM	-	EV/Sales	2.24	EPS Y/Y TTM	3.61%	Oper. Margin	-44.08%	ATR (14)	0.38	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.12	Sales Y/Y TTM	4.49%	Profit Margin	-105.24%	RSI (14)	57.20	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.49	EPS Q/Q	51.12%	SMA20	5.50%	Beta	0.48	Target Price	10.00
Payout	-	Debt/Eq	0.03	Sales Q/Q	-16.50%	SMA50	8.91%	Rel Volume	0.90	Prev Close	6.20
Employees	246	LT Debt/Eq	0.03	Earnings	Nov 10 BMO	SMA200	0.44%	Avg Volume	451.46K	Price	6.55
IPO	Dec 18, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	71.86% 3.18%	Trades		Volume	404,425	Change	5.65%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-05-25	Upgrade	Leerink Partners	Market Perform → Outperform	$12
Nov-13-24	Downgrade	Leerink Partners	Outperform → Market Perform	$12 → $4
Feb-07-23	Initiated	Stephens	Overweight	$14
Oct-15-21	Resumed	Cowen	Outperform
Jan-12-21	Initiated	William Blair	Outperform
Jan-12-21	Initiated	SVB Leerink	Outperform	$70
Jan-12-21	Initiated	Stifel	Buy	$65
Jan-12-21	Initiated	Cowen	Outperform

Feb-05-26 07:00AM	908 Devices Enhances MX908 Usability and Adds New Drug Targets (Business Wire)
Jan-21-26 04:58PM	Cathie Wood Has 13 Big Ideas For 2026: Here's The Ark Invest List And Stocks To Watch (Benzinga)
05:41AM	908 Devices (MASS) Moves 19.2% Higher: Will This Strength Last? (Zacks)
Jan-20-26 07:00AM	908 Devices Announces Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025 (Business Wire) +19.20%
Nov-10-25 04:01PM	908 Devices Inc (MASS) Q3 2025 Earnings Call Highlights: Navigating Revenue Challenges and ... (GuruFocus.com) -13.35% -7.82%
08:15AM	Loading…
08:15AM	908 Devices Inc. (MASS) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
07:00AM	908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook (Business Wire)
Nov-07-25 07:22AM	What To Expect From 908 Devices Inc (MASS) Q3 2025 Earnings (GuruFocus.com) -5.38%
Nov-06-25 06:55PM	Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
10:00AM	Envoy Medical, Inc. (COCH) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Nov-05-25 06:00PM	Penumbra (PEN) Q3 Earnings and Revenues Beat Estimates (Zacks)
Nov-04-25 08:15AM	InspireMD, Inc. (NSPR) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
Nov-03-25 10:00AM	Will 908 Devices Inc. (MASS) Report Negative Earnings Next Week? What You Should Know (Zacks)
Oct-30-25 07:00AM	908 Devices to Participate in Upcoming Investor Conferences (Business Wire)
Oct-28-25 07:00AM	United States Coast Guard Purchases 908 Devices' Handheld Mass Spec Devices for Chemical Threat Identification (Business Wire)
07:00AM	Loading…
Oct-22-25 07:00AM	908 Devices to Report Third Quarter 2025 Financial Results on November 10, 2025 (Business Wire) -5.36%
Oct-16-25 07:00AM	United States Marine Corps Purchases 908 Devices' XplorIR Gas Identification Devices (Business Wire)
Sep-22-25 08:57AM	908 Devices (MASS) Surges 7.0%: Is This an Indication of Further Gains? (Zacks)
Aug-05-25 08:20AM	908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:00AM	908 Devices Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Outlook (Business Wire)
Aug-04-25 10:07AM	Earnings To Watch: 908 Devices Inc (MASS) Reports Q2 2025 Result (GuruFocus.com)
07:00AM	908 Devices Appoints Dr. Brandi Vann, former U.S. Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense, to its Board of Directors (Business Wire)
Jul-29-25 07:00AM	908 Devices to Participate in the Canaccord Genuity 45th Annual Growth Conference (Business Wire) -5.18%
Jul-22-25 07:00AM	908 Devices to Report Second Quarter 2025 Financial Results on August 5, 2025 (Business Wire)
Jul-09-25 10:45AM	Innovation ETF (ARKK) Hits New 52-Week High (Zacks)
Jul-08-25 07:00AM	908 Devices Launches VipIR, a 3-in-1 Handheld Analyzer for Field-Based Chemical Identification of Unknown Bulk Substances (Business Wire) +6.24%
Jun-26-25 12:00PM	908 Devices (MASS) Upgraded to Buy: Here's What You Should Know (Zacks)
Jun-25-25 08:03AM	Asylon Robotics and 908 Devices Deliver Robotic Security at the 2025 Indianapolis 500 (Business Wire)
Jun-16-25 08:00AM	908 Devices Appoints Christopher D. Brown to its Board of Directors (Business Wire)
Jun-03-25 07:00AM	Metropolitan Washington Council of Governments Adds 908 Devices' XplorIR to Its Hazardous Materials Response Toolkit (Business Wire) +11.26%
06:04PM	Loading…
May-30-25 06:04PM	Why 908 Devices Stock Rocketed More Than 18% Higher This Week (Motley Fool)
May-28-25 07:00AM	Romanian Customs Authority Adopts 908 Devices MX908 for Border Security Operations (Business Wire) +9.56%
May-26-25 12:00PM	All You Need to Know About 908 Devices (MASS) Rating Upgrade to Buy (Zacks)
May-22-25 07:00AM	908 Devices to Participate in the William Blair 45th Annual Growth Stock Conference (Business Wire)
May-14-25 05:38AM	Q1 2025 908 Devices Inc Earnings Call (Thomson Reuters StreetEvents) -7.10%
03:08AM	908 Devices Inc (MASS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Rising Losses (GuruFocus.com)
May-13-25 08:30AM	Bet On 4 Low-Beta Stocks BWB, LRN, MASS & PM Despite Tariff Truce (Zacks) -18.85%
08:15AM	908 Devices Inc. (MASS) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:00AM	908 Devices Reports First Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook (Business Wire)
May-12-25 09:41AM	What To Expect From 908 Devices Inc (MASS) Q1 2025 Earnings (GuruFocus.com)
May-08-25 11:28PM	908 Devices Inc. (MASS): Among Nicholas J. Pritzker's Stock Picks with Huge Upside Potential (Insider Monkey) +6.63%
May-07-25 05:55PM	Inogen (INGN) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
10:00AM	Will Lucid Diagnostics Inc. (LUCD) Report Negative Earnings Next Week? What You Should Know (Zacks)
May-06-25 10:00AM	908 Devices Inc. (MASS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
08:25AM	Avanos Medical (AVNS) Q1 Earnings and Revenues Top Estimates (Zacks)
May-05-25 10:33AM	MTD Q1 Earnings Top Estimates, Sales Decline Y/Y, Shares Rise (Zacks)
Apr-30-25 07:00AM	908 Devices Equips rescEU Disaster Preparedness Reserve with Advanced Chemical Detection (Business Wire)
05:48AM	Why 908 Devices Inc. (MASS) is Surging in 2025 (Insider Monkey)
Apr-29-25 11:50PM	Q1 2025 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
Apr-23-25 08:29AM	Buy 4 Low-Beta Stocks ANIP, LRN, MASS & CTGO as Tariff Woes Continue (Zacks)
Apr-22-25 07:00AM	908 Devices Receives $2M Order from the Texas Department of Public Safety for Drug Detection and Mitigation (Business Wire) +17.92%
Apr-16-25 11:59AM	Big banks report Q1 beats, China stops taking Boeing deliveries: Morning Buzz (TipRanks)
Apr-15-25 07:00AM	908 Devices Announces Preliminary First Quarter 2025 Financial Results (Business Wire)
Apr-08-25 05:58AM	The Zacks Analyst Blog Highlights Fidelity NASDAQ Composite Index ETF, ThredUp, 908 Devices, Logility Supply Chain, Palomar and EZCORP (Zacks)
Apr-07-25 08:00AM	5 Top-Ranked Stocks of Nasdaq ETF Beating the Bear Market (Zacks)
Apr-01-25 06:55AM	New Strong Buy Stocks for April 1st (Zacks) -9.15%
Mar-11-25 07:00AM	908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device (Business Wire) +14.57%
Mar-05-25 05:14AM	Q4 2024 908 Devices Inc. Earnings Call (Thomson Reuters StreetEvents) -13.14%
02:05AM	908 Devices Inc (MASS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ... (GuruFocus.com)
Mar-04-25 01:26PM	908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth (Benzinga) +95.96%
09:30AM	908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:45AM	908 Devices Announces Strategic Transformation and Reports Fourth Quarter and Full Year 2024 Financial Results (Business Wire)
07:30AM	Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices (Business Wire)
Mar-03-25 05:00PM	908 Devices to Participate in Upcoming Investor Conferences (Business Wire) -11.61%
04:30PM	908 Devices to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 (Business Wire)
Jan-14-25 04:01PM	908 Devices Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results (Business Wire) +46.97%
Dec-19-24 07:00AM	Getinge and 908 Devices Partner to Enhance Bioreactor Capabilities for Continuous Monitoring of Key Cell Culture Parameters (Business Wire)
Nov-13-24 02:10AM	908 Devices Inc (MASS) Q3 2024 Earnings Call Highlights: Revenue Growth Amidst Challenges (GuruFocus.com) -19.86%
Nov-12-24 08:15AM	908 Devices Inc. (MASS) Reports Q3 Loss, Lags Revenue Estimates (Zacks) -19.34%
07:00AM	908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook (Business Wire)
Nov-11-24 07:21AM	What To Expect From 908 Devices Inc (MASS) Q3 2024 Earnings (GuruFocus.com)
Nov-04-24 07:00AM	908 Devices to Participate in Upcoming Investor Conferences (Business Wire)
Oct-22-24 07:00AM	908 Devices to Report Third Quarter 2024 Financial Results on November 12, 2024 (Business Wire)
Oct-09-24 05:02PM	908 Devices Inc (MASS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges (GuruFocus.com)
Sep-06-24 07:00AM	908 Devices to Participate in Craig-Hallum Bioprocessing Conference (Business Wire)
Aug-06-24 08:20AM	908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:00AM	908 Devices Reports Second Quarter 2024 Financial Results and Reiterates 2024 Revenue Outlook (Business Wire)
Jul-30-24 10:01AM	Earnings Preview: 908 Devices Inc. (MASS) Q2 Earnings Expected to Decline (Zacks)
07:00AM	908 Devices to Participate in Canaccord Genuity 44th Annual Growth Conference (Business Wire)
Jul-23-24 07:00AM	908 Devices to Report Second Quarter 2024 Financial Results on August 6, 2024 (Business Wire)
Jun-25-24 07:00AM	908 Devices Appoints Michele M. Leonhart, Former Administrator of the United States Drug Enforcement Administration (DEA), to Its Board of Directors (Business Wire)
Jun-18-24 07:00AM	908 Devices Enhances XplorIR Portable Analyzer to Simultaneously Identify and Quantify Hazardous Gases and Vapors (Business Wire)
Jun-07-24 03:24AM	Should You Hold 908 Devices (MASS)? (Insider Monkey)
May-15-24 07:00AM	908 Devices to Participate in Upcoming Investor Conferences (Business Wire)
May-14-24 09:55AM	Wall Street Analysts Predict a 133.69% Upside in 908 Devices (MASS): Here's What You Should Know (Zacks) +8.99%
May-09-24 09:35AM	908 Devices (MASS) Loses -9.95% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
May-01-24 08:49AM	908 Devices Inc. (NASDAQ:MASS) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:09AM	908 Devices Inc (MASS) (Q1 2024) Earnings Call Transcript Highlights: Strategic Acquisitions ... (GuruFocus.com)
12:08AM	Q1 2024 908 Devices Inc. Earnings Call (Thomson Reuters StreetEvents)
Apr-30-24 11:53AM	MASS Stock Earnings: 908 Devices Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
09:35AM	908 Devices Inc (MASS) Q1 2024 Earnings: Narrower Losses and Revenue Growth (GuruFocus.com)
08:55AM	908 Devices Inc. (MASS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:45AM	908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook (Business Wire)
07:30AM	908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering (Business Wire)
Apr-23-24 07:00AM	908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024 (Business Wire)
Mar-12-24 07:00AM	908 Devices Trace Chemical Identification Technology Adopted by European Agencies (Business Wire) +5.41%
Mar-07-24 12:02PM	908 Devices Inc. (NASDAQ:MASS) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-05-24 07:33AM	908 Devices Inc (MASS) Reports Growth Amidst Industry Headwinds (GuruFocus.com)
07:00AM	908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook (Business Wire)
Feb-29-24 07:00AM	908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares Fully Integrated Cell Therapy Manufacturing Platform (Business Wire)

908 Devices, Inc. engages in the development of measurement devices for chemical and biochemical analysis. It offers products using mass spectrometry technology, an analytical technique for measuring the mass of charged molecules that is used in chemical analysis laboratories for applications, such as safety and security, food science, biotechnology, clinical diagnostics, and controlling industrial processes. Its products include desktops and handhelds. The company was founded by Kevin J. Knopp, Miller Scott, Steve Araiza, Andrew Bartfay, Michael Jobin, Christopher D. Brown, and Christopher J. Petty in 2012 and is headquartered in Burlington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Knopp Kevin J.	President and CEO	Feb 02 '26	Sale	6.18	34,764	214,842	795,968	Feb 03 08:45 PM
Griffith Joseph H. IV	Chief Financial Officer	Feb 02 '26	Sale	6.18	23,175	143,222	139,896	Feb 03 08:45 PM
Griffith Joseph H. IV	Chief Financial Officer	Oct 03 '25	Sale	9.05	4,292	38,849	92,930	Oct 06 12:41 PM
Griffith Joseph H. IV	Chief Financial Officer	Oct 02 '25	Sale	9.04	708	6,398	97,222	Oct 06 12:41 PM
JOSEPH H GRIFFITH IV	Officer	Oct 02 '25	Proposed Sale	8.99	5,000	44,950		Oct 02 04:24 PM
Griffith Joseph H. IV	Chief Financial Officer	Sep 19 '25	Sale	7.07	5,000	35,338	97,930	Sep 23 12:33 PM
JOSEPH H GRIFFITH IV	Officer	Sep 19 '25	Proposed Sale	6.82	5,000	34,100		Sep 19 04:26 PM
Turner Michael S.	Chief Legal & Admin Officer	Jun 16 '25	Sale	7.51	16,082	120,839	8,521	Jun 18 04:35 PM
Turner Michael S.	Chief Legal & Admin Officer	Jun 17 '25	Sale	7.51	7,148	53,653	1,373	Jun 18 04:35 PM
Turner Michael S.	Chief Legal & Admin Officer	Jun 18 '25	Sale	7.50	1,373	10,298	0	Jun 18 04:35 PM
MICHAEL S TURNER	Officer	Jun 16 '25	Proposed Sale	7.31	24,603	179,848		Jun 16 04:24 PM
Griffith Joseph H. IV	Chief Financial Officer	Jun 04 '25	Sale	7.08	6,940	49,135	102,930	Jun 06 05:51 PM
JOSEPH H GRIFFITH IV	Officer	Jun 04 '25	Proposed Sale	6.62	6,940	45,943		Jun 04 04:26 PM
Knopp Kevin J.	President and CEO	May 15 '25	Buy	4.44	15,000	66,596	722,733	May 19 04:37 PM
Spoto Mark	Director	May 14 '25	Buy	4.29	10,000	42,850	62,971	May 15 04:52 PM
Knopp Kevin J.	President and CEO	May 14 '25	Buy	4.32	15,000	64,788	707,733	May 14 04:28 PM

QTRX

Quanterix Corp

MASS

908 Devices Inc

Upgrade your FINVIZ experience